scholarly journals HEPATIC STEATOSIS IS INDEPENDENTLY ASSOCIATED WITH HYPERREACTIVE BLOOD PRESSURE RESPONSE ON THE EXERCISE STRESS TEST

2012 ◽  
Vol 59 (13) ◽  
pp. E1793
Author(s):  
Antonio Laurinavicius ◽  
Fernando Nary ◽  
Michael Blaha ◽  
Khurram Nasir ◽  
Raquel Conceicao ◽  
...  
Stroke ◽  
2001 ◽  
Vol 32 (9) ◽  
pp. 2036-2041 ◽  
Author(s):  
S. Kurl ◽  
J.A. Laukkanen ◽  
R. Rauramaa ◽  
T.A. Lakka ◽  
J. Sivenius ◽  
...  

2020 ◽  
Vol 22 (Supplement_N) ◽  
pp. N16-N16
Author(s):  
Francesca Bellomo ◽  
Mariapaola Campisi ◽  
Giuseppe Lantone ◽  
Paolo Mazzone ◽  
Giorgio Firetto ◽  
...  

Abstract Aims The aim of this multicentre registry was to verify the association between an exaggerated blood pressure response (EBPR) to exercise stress test (EST) and evidence of previous myocardial and/or brain ischaemic events in the general population. Methods and results All subjects who underwent EST for screening of ischaemic heart disease and/or follow-up and re-evaluation of heart disease were included in the registry. Patients who discontinued EST due to early muscle exhaustion, younger individuals (<18 years), patients with potentially dangerous channelopathies or ventricular arrhythmias, as well as those with disabling chronic diseases or experiencing cardiovascular events in the 3 months prior to TE. Everyone performed EST on a treadmill or cycle ergometer using similar protocols in the various centres. Based on some study in the literature, we identified the EBPR to exercise for a systolic BP rise >60 mmHg (men) or > 50 mmHg (women) compared to pre-exercise baseline measurement, but also an absolute value >210 or > 190 mmHg, respectively. Retrospectively, we verified the presence of non-disabling ischaemic cardiac and cerebrovascular events over the past 10 years. Five hundred and three subjects of mean age 61 ± 11 years were included in the registry. EST was performed on a treadmill in 65% of subjects and maximal workload was achieved by 75% of them. Subjects with EBPR were 170 (34%) vs. 333 (66%) who had normal response (controls). EBPR group included most male subjects, often overweight and with a higher prevalence of diabetes (31% vs. 20% in the control group, P < 0.01), and with already diagnosed arterial hypertension in a half of cases. Previous ischaemic myocardial events were found in 35% of EBPR subjects vs. 36% of controls (P = NS), while cerebrovascular disease in 20% vs. 10%, respectively (P < 0.005). Conclusion Albeit retrospectively performed, this multicentre registry highlighted an association between EBPR to exercise (present in more than one-third of the subjects examined, especially males) and history of cerebrovascular ischaemic events within 10 years prior to enrolment. In line with previous studies, present data confirmed a clinical impact of EBPR on exercise. However, the precise pathophysiological mechanism(s) need to be clarified yet, also in terms of therapies against such exaggerated functional response and its possible prognostic impact over time.


2019 ◽  
Vol 67 (2) ◽  

The actual significance and definition of hypertensive response to exercise (HRE) is still debated. Up to now, there is consensus in defining it as a systolic blood pressure value of either ≥ 210 mmHg in men and ≥ 190 mmHg in women or a diastolic blood pressure ≥ 110 mmHg during maximal exercise stress test. The mechanisms underlying an exaggerated blood pressure response to exercise are poorly understood; however, there are studies suggesting that HRE may represent a preclinical stadium of essential hypertension, which shares several common pathological mechanisms mostly related to an endothelial dysfunction and vascular stiffness. In this article we review the present knowledge with particular respect to prognostic significance and diagnostic and therapeutic strategies in different populations. A separate section is dedicated to athletes with HRE.


2019 ◽  
Vol 28 (5) ◽  
pp. 742-751 ◽  
Author(s):  
Benjamin T. Fitzgerald ◽  
Emma L. Ballard ◽  
Gregory M. Scalia

Cholesterol ◽  
2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Amanda L. Zaleski ◽  
Marianne L. Mentch ◽  
Linda S. Pescatello ◽  
Beth A. Taylor ◽  
Jeffrey A. Capizzi ◽  
...  

Statins are the most widely prescribed and effective medication for reducing low density lipoprotein cholesterol. Statins may also lower resting blood pressure (BP); however, results are inconsistent. We sought to determine if the maximum dose of atorvastatin reduces resting BP and the peak systolic BP (SBP) achieved on a graded exercise stress test (GEST) among a large sample of 419 healthy men (48%) and women (52%). Subjects (419, 44.1±0.8 yr) were double-blinded and randomized to 80 mg·d−1 of atorvastatin (n=202) or placebo (n=217) for 6 mo. Among the total sample, there were no differences in resting BP (SBP, P=0.30; diastolic BP [DBP], P=0.69; mean arterial pressure (P=0.76); or peak SBP on a GEST (P=0.99)) over 6 mo, regardless of drug treatment group. However, among women on atorvastatin, resting SBP/DBP (3.7±1.5 mmHg, P=0.01/3.2±0.9 mmHg, P=0.02) and peak SBP on a GEST (6.5±1.5 mmHg, P=0.04) were lower versus men. Atorvastatin lowered resting BP 3-4 mmHg and peak SBP on a GEST ~7 mmHg more among women than men over 6 mo of treatment. The inconsistent findings regarding the antihypertensive effects of statins may be partially explained by not accounting for sex effects.


QJM ◽  
2016 ◽  
Vol 109 (8) ◽  
pp. 531-537 ◽  
Author(s):  
A.G. Laurinavicius ◽  
M.S. Bittencourt ◽  
M.J. Blaha ◽  
F.C. Nary ◽  
N.M. Kashiwagi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document